Medicines and other products based on cannabis or cannabidiol

The use of medicinal cannabis is strictly regulated in Belgium and limited to specific situations. This webpage provides answers to questions on the current legislation, the medicinal cannabis products available and the conditions under which these products can be prescribed, dispensed and used. 

What is medicinal cannabis?

Medicinal cannabis includes products that: 

BELMAP reports

In Belgium, antimicrobial use (AMU) and antimicrobial resistance (AMR) are monitored in various contexts, including human medicine, food-producing animals and the food chain. As the results of these different programmes are reported separately, it can be difficult to obtain a clear overview of trends in AMR and AMCs across all sectors in Belgium.

EMA publishes new data on sales and use of antimicrobials in animals within the European Union

The European Medicines Agency publishes the second European Sales and Use of Antimicrobials for Veterinary Medicine report and launches a new platform to improve monitoring of data on the use of antimicrobials in animals. The report shows a slight increase in antimicrobial sales, an increase of 5 % in 2024 compared to 2023.

Donor TP53 - What measures have been taken in Belgium?

The European press has published information about a Danish sperm donor who carries a rare genetic mutation (TP53). Many European countries have been affected by this. In Belgium, this case has received extensive media coverage since May 2025, and several parliamentary hearings have taken place in which the FAGG responded to questions from federal parliamentarians.

Fosmanogepix

Active substance    Manogepix
Holder WEP Clinical Ireland Ltd
Status Running
Indication Treatment of patients with Invasive Mold Infections (IMIs).
Public documents Approbation
 

New Royal Decree on parallel distribution and parallel import of medicinal products for human use effective from 11 December 2025

From 11 December 2025, a new Royal Decree will come in force that fundamentally changes the rules on parallel distribution and parallel import of medicinal products for human use in Belgium. The decree simplifies administrative steps and provides more transparency.
Subscribe to